Cervical cancer morbidity and mortality have decreased substantially during the last 50 years mostly due to successful organized or opportunistic screening with Pap cytology in high and middle income countries. In many low income countries Pap cytology screening is yet to be effectively implemented or has failed to reduce cervical cancer rates to an appreciable extent. The fact that infection w...

BACKGROUND Primary cervical screening with both human papillomavirus (HPV) DNA testing and cytological examination of cervical cells with a Pap test (cytology) has been evaluated in randomized clinical trials. Because the vast majority of women with positive cytology are also HPV DNA positive, screening strategies that use HPV DNA testing as the primary screening test may be more effective. M...

Human papillomavirus (HPV) testing is used in primary cervical screening, as an adjunct to cervical cytology for the management of low grade abnormal cytology, and in a test of cure. PapilloCheck (Greiner Bio-One) is a PCR-based DNA microarray system that can individually identify 24 HPV types, including the 13 high-risk (HR) types identified by Hybrid Capture 2 (HC2). Here, we compare PapilloC...

BACKGROUND The prevalence of cervical intraepithelial neoplasia (CIN) is increased in HIV infection. The UK National Health Service Cervical Screening Programme (NHSCSP) guidelines therefore provide specific recommendations for HIV-positive women. An audit of cervical surveillance in HIV-positive women who attend the genitourinary medicine (GUM) department at the Leicester Royal Infirmary, Leic...

OBJECTIVE The aim of this study was to determine the prevalence of cervical Chlamydia trachomatis infection by polymerase chain reaction (PCR) in urban women undergoing routine cervical cytological screening and to investigate the relationship with age, cytology, smoking status and concurrent human papillomavirus (HPV) infection. METHODS A total of 996 women (age range 16-69 years) attending ...

Background: Cervical cancer presents as major cause of morbidity and mortality especially in developing countries like India. Various screening programs are implemented for its early detection and treatment, which makes it imperative to have a reliable screening investigation for wider application. Objective : TO evaluate the role of Liquid base cytology and Colposcopy and compare their efficac...

BACKGROUND Cervical cancer is the leading cause of cancer morbidity and mortality among women in Nepal and Bhutan. Data on high-risk human papillomavirus (HR-HPV) infection and cervical abnormalities among Nepali and Bhutanese women are sparse. The objectives of this study were to assess and compare the prevalence of HR-HPV infection and cervical abnormalities among Nepali and Bhutanese women l...

page 2, line 12, «screening with cervical cytology (old policy)» => «screening with cervical cytology with HPV-test in triage of ASC-US / LSIL (old policy)» Abstract, page 2, line 12-14, «screening with HPV testing, followed by triage with cytology (new policy)» => screening with HPV-test with cytology in triage of HPV positive (new policy)» page 2, line 12-14, «screening with HPV testing, foll...

Primary human papillomavirus (HPV)-based cervical screening will be introduced in the Netherlands in 2016. We assessed the 5-year cervical (pre)cancer risk of women with different combinations of HPV and cytology test results. Special attention was paid to risks for cervical intraepithelial neoplasia grade 3 and 2 or more (CIN3+/2+) of HPV-positive women with a negative triage test, because thi...

No longer is there argument that cervical screening can reduce deaths from cervical cancer. There is also agreement that the incidence of cervical intraepithelial neoplasia has risen appreciably in recent years' 2 and that without intervention deaths from cervical cancer in the 1990s will rise by 70% or more. The debate is now centring on what proportion of cases of cervical intraepithelial neo...